1Isaacson PG, Chott A, Nakamura S, et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer (IARC) Press, 2008. 214-217.
2Chng wJ, Remstein ED, Fonseca R, et al. Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications. Blood, 2009, 113(3): 635-645.
3Imai H, Sunaga N, Kaira K, et al. Clinicopathological features of patients with bronchial-associated lymphoid tissue lymphoma. Int Med, 2009, 48(5): 301-306.
4Oh SY, Kim WS, Kim JS, et al. Pulmonary marginal zone B-cell lymphoma of MALT type-What is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for improving Survival of Lymphoma (CISL) Study. Ann Hematol, 2010, 89(6): 563-568.
5Bae YA, Lee KS, HanJ, et al. Marginal zone B-cell lymphoma of bronchus- associated lymphoid tissue (BALT): imaging findings in 21 patients. Chest, 2008, 133(2): 433-440.
6Borie R, Wislez M, Thabut G, et al. Clinical characteristics and prognostic factors of pulmonary MALT lymphoma. Eur Respir J, 2009, 34(6):1408-1416.
7Maksimovic O, Bethge WA, Pintoffl Jp, et al. Marginal zone B-cell non- Hodgkin's lymphoma of mucosa-associated lymphoid tissue type: imaging findings. AJRAmJ Roentgenol, 2008, 191(3): 921-930.
8Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir J, 2002, 20(3): 750-762.
9Bacon CM, Du MQ Dogan A. Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists. J Clin Pathol, 2007, 60(4): 361-372.
10Stefanovic A, Morgensztern D, Fong T, et al. Pulmonary marginal zone lymphoma: a single centre experience and review of the SEER database. Leuk Lymphoma, 2008, 49(7): 1311-1320.
